Nuclear Nrf2 Induction by Protein Transduction Attenuates Osteoclastogenesis
Nuclear Nrf2 Induction by Protein Transduction Attenuates Osteoclastogenesis
复制标题
DOI:
10.1016/j.freeradbiomed.2014.09.006
复制
发表时间:
2014-12-01
影响因子:
7.4
通讯作者:
Nakamura, Yoshiki
中科院分区:
文献类型:
--
作者:
Kanzaki, Hiroyuki;Shinohara, Fumiaki;Nakamura, Yoshiki
It has been reported that reactive oxygen species (ROS) play a role as intracellular signaling molecules in RANKL stimulation. Previously we demonstrated that induction of cytoprotective enzyme expression by Nrf2-gene transfer successfully ameliorated RANKL-dependent osteoclastogenesis. In the present study, we hypothesized that Nrf2 activation by inhibiting ubiquitination and degradation of Nrf2 by ETGE-peptide would induce Nrf2-dependent cytoprotective enzyme expression, attenuate ROS signaling, and thereby inhibit RANKL-dependent osteoclastogenesis. ETGE-peptide containing a cell-permeable sequence (seven consecutive arginine; 7R-ETGE) was applied to a mouse macrophage cell-line RAW 264.7 cell or a primary macrophage culture. ETGE-peptide prevents Keap1 from binding to Nrf2. Nrf2 nuclear translocation and Nrf2-dependent cytoprotective enzyme induction was observed. The effects of 7R-ETGE on RANKL-dependent induction of intracellular ROS levels and osteodastogenesis were examined. Finally, the protective effect of 7R-ETGE on RANICL-mediated bone destruction was investigated in mice. 7R-ETGE dose-dependently induced nuclear Nrf2, followed by the induction of cytoprotective enzyme expression at both the gene and protein level. 7R-ETGE inhibited upregulation of intracellular ROS levels by RANKL stimulation, and osteoclastogenesis was attenuated. Of particular interest was that local injection of 7R-ETGE ameliorated RANKL-mediated bone destruction. Local induction of nuclear Nrf2 by protein transduction is a potential novel therapeutic target for bone destruction diseases such as periodontitis and rheumatoid arthritis. (C) 2014 The Authors. Published by Elsevier Inc.